Remifentanil-based analgesia and sedation facilitates more rapid and predictable time to neurological assessments

Documenti analoghi

• The safety of remifentanil administered for up to 5 days in ICU patients with neurotrauma
  di: Stergiopoulos, S, et al.
  Pubblicazione: (2004)
• Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]
  di: Karabinis, Andreas, et al.
  Pubblicazione: (2004)
• Decreased time on mechanical ventilation using remifentanil-based analgesia and sedation
  di: Malbrain, M, et al.
  Pubblicazione: (2004)
• Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients
  di: Karabinis, A, et al.
  Pubblicazione: (2004)
• Remifentanil for analgesia-based sedation in the intensive care unit
  di: Kuhlen, Ralf, et al.
  Pubblicazione: (2004)